COMPARISON OF RISK FACTORS FOR WARFARINASSOCIATED BLEEDING

Basit Öğe Kaydı
dc.authorscopusid57190585404
dc.authorscopusid57386826100
dc.contributor.authorÖzgenel Ş.M.
dc.contributor.authorDemir A.M.
dc.date.accessioned2024-06-12T10:26:35Z
dc.date.available2024-06-12T10:26:35Z
dc.date.issued2023
dc.description.abstractObjectives: Warfarin is the most commonly used oral agent for long-term anticoagulation. Nevertheless, bleeding is the most frequent side effect of warfarin, increasing mortality and morbidity and thereby restricting its use. Risk factors for bleeding include age, comorbid diseases, use of drugs that may interact with warfarin, and previous history of stroke or gastrointestinal bleeding. Using a questionnaire-based method, this study aimed to compare the risk of bleeding in two groups of warfarin users with and without a history of warfarin-related bleeding. Materials and Methods: A total of 201 patients, including 100 who had bleeding during warfarin use in our outpatient clinic and 101 patients who were followed up with the international normalization rate, were included in the study. Risk factors in warfarin-related bleeding were evaluated by the researcher with a questionnaire created as a result of the literature review. Data were statistically analyzed. Results: The prevalence of bleeding was 2.8 times higher in patients aged 65 years and older (confidence interval: 1.40-5.56) and 5.6 times higher in patients with comorbid diseases (confidence interval: 1.376-22.770). A history of stroke increased major bleeding 3.2 fold (confidence interval: 1.08-9.61). We also observed that lack of education might be a risk factor for warfarin-related bleeding. Conclusion: We believe that older patients under warfarin treatment should be informed according to their education status, and their medications and comorbid diseases should be monitored regularly by the same centers. © Annals of Translational Medicine. All rights reserved.en_US
dc.identifier.doi10.5505/amj.2023.95825
dc.identifier.endpage131en_US
dc.identifier.issn1303-2283
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85153951176en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage120en_US
dc.identifier.urihttps://doi.org/10.5505/amj.2023.95825
dc.identifier.urihttps://hdl.handle.net/20.500.14551/16905
dc.identifier.volume23en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherAnkara Yildirim Beyazit Universityen_US
dc.relation.ispartofAnkara Medical Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBleeding; Oral Anticoagulation; Risk; Warfarinen_US
dc.titleCOMPARISON OF RISK FACTORS FOR WARFARINASSOCIATED BLEEDINGen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu